These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
152 related items for PubMed ID: 22575725
21. Insulin Receptor Substrate 1 Gly972Arg (rs1801278) Polymorphism Is Associated with Obesity and Insulin Resistance in Kashmiri Women with Polycystic Ovary Syndrome. Rasool SUA, Nabi M, Ashraf S, Amin S. Genes (Basel); 2022 Aug 17; 13(8):. PubMed ID: 36011374 [Abstract] [Full Text] [Related]
22. Genetic polymorphisms of INS, INSR and IRS-1 genes are not associated with polycystic ovary syndrome in Croatian women. Skrgatić L, Baldani DP, Gersak K, Cerne JZ, Ferk P, Corić M. Coll Antropol; 2013 Mar 17; 37(1):141-6. PubMed ID: 23697264 [Abstract] [Full Text] [Related]
23. Prevalence of the insulin receptor substrate-1(IRS-1) Gly972Arg and the insulin receptor substrate-2(IRS-2) Gly1057Asp polymorphisms in PCOS patients and non-diabetic healthy women. Rashidi B, Azizy L, Najmeddin F, Azizi E. J Assist Reprod Genet; 2012 Feb 17; 29(2):195-201. PubMed ID: 22205343 [Abstract] [Full Text] [Related]
24. A meta-analysis on the association between PPAR-γ Pro12Ala polymorphism and polycystic ovary syndrome. He J, Wang L, Liu J, Liu F, Li X. J Assist Reprod Genet; 2012 Jul 17; 29(7):669-77. PubMed ID: 22527903 [Abstract] [Full Text] [Related]
25. Association of IRS-1 and IRS-2 genes polymorphisms with polycystic ovary syndrome: a meta-analysis. Ruan Y, Ma J, Xie X. Endocr J; 2012 Jul 17; 59(7):601-9. PubMed ID: 22523112 [Abstract] [Full Text] [Related]
26. Association of the Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma2 with decreased basic metabolic rate in women with polycystic ovary syndrome. Koika V, Marioli DJ, Saltamavros AD, Vervita V, Koufogiannis KD, Adonakis G, Decavalas G, Georgopoulos NA. Eur J Endocrinol; 2009 Aug 17; 161(2):317-22. PubMed ID: 19465486 [Abstract] [Full Text] [Related]
27. Influence of tumour suppressor gene (TP53, BRCA1 and BRCA2) polymorphisms on polycystic ovary syndrome in South Indian women. Siddamalla S, Reddy TV, Govatati S, Guruvaiah P, Deenadayal M, Shivaji S, Bhanoori M. Eur J Obstet Gynecol Reprod Biol; 2018 Aug 17; 227():13-18. PubMed ID: 29860059 [Abstract] [Full Text] [Related]
28. Gly972Arg of IRS-1 and Lys121Gln of PC-1 polymorphisms act in opposite way in polycystic ovary syndrome. Pappalardo MA, Vita R, Di Bari F, Le Donne M, Trimarchi F, Benvenga S. J Endocrinol Invest; 2017 Apr 17; 40(4):367-376. PubMed ID: 27785750 [Abstract] [Full Text] [Related]
29. Associations of insulin receptor and insulin receptor substrates genetic polymorphisms with polycystic ovary syndrome: A systematic review and meta-analysis. Shi X, Xie X, Jia Y, Li S. J Obstet Gynaecol Res; 2016 Jul 17; 42(7):844-54. PubMed ID: 27098445 [Abstract] [Full Text] [Related]
30. Association of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma with polycystic ovary syndrome: a meta-analysis. Tang ST, Wang CJ, Tang HQ, Peng WJ, Wang YM, Zhang Q. Mol Biol Rep; 2012 Oct 17; 39(10):9649-60. PubMed ID: 22729915 [Abstract] [Full Text] [Related]
31. Genetic variation in exon 17 of INSR is associated with insulin resistance and hyperandrogenemia among lean Indian women with polycystic ovary syndrome. Mukherjee S, Shaikh N, Khavale S, Shinde G, Meherji P, Shah N, Maitra A. Eur J Endocrinol; 2009 May 17; 160(5):855-62. PubMed ID: 19211708 [Abstract] [Full Text] [Related]
32. The role of epistasis in the etiology of Polycystic Ovary Syndrome among Indian women: SNP-SNP and SNP-environment interactions. Dasgupta S, Reddy BM. Ann Hum Genet; 2013 Jul 17; 77(4):288-98. PubMed ID: 23550965 [Abstract] [Full Text] [Related]
33. Vitamin D receptor gene polymorphisms and risk of polycystic ovary syndrome in South Indian women. Siddamalla S, Reddy TV, Govatati S, Erram N, Deenadayal M, Shivaji S, Bhanoori M. Gynecol Endocrinol; 2018 Feb 17; 34(2):161-165. PubMed ID: 28868946 [Abstract] [Full Text] [Related]
34. The prevalence of Gly972Arg and C825T polymorphisms in Slovak women with polycystic ovary syndrome and their relation to the metabolic syndrome. Dravecká I, Lazúrová I, Habalová V. Gynecol Endocrinol; 2010 May 17; 26(5):356-60. PubMed ID: 20170352 [Abstract] [Full Text] [Related]
35. Association between the Pro12Ala polymorphism of PPAR-γ gene and the polycystic ovary syndrome: a meta-analysis of case-control studies. Zhang H, Bi Y, Hu C, Lu W, Zhu D. Gene; 2012 Jul 15; 503(1):12-7. PubMed ID: 22564702 [Abstract] [Full Text] [Related]
36. Association of peroxisome proliferator-activated receptorgamma gene Pro12Ala and C161T polymorphisms with metabolic syndrome. Dongxia L, Qi H, Lisong L, Jincheng G. Circ J; 2008 Apr 15; 72(4):551-7. PubMed ID: 18362424 [Abstract] [Full Text] [Related]
37. The role of genetic variation in peroxisome proliferator-activated receptors in the polycystic ovary syndrome (PCOS): an original case-control study followed by systematic review and meta-analysis of existing evidence. San-Millán JL, Escobar-Morreale HF. Clin Endocrinol (Oxf); 2010 Mar 15; 72(3):383-92. PubMed ID: 19681917 [Abstract] [Full Text] [Related]
38. Evaluation of glucose metabolism and reproductive hormones in polycystic ovary syndrome on the basis of peroxisome proliferator-activated receptor (PPAR)-gamma2 Pro12Ala genotype. Tok EC, Aktas A, Ertunc D, Erdal EM, Dilek S. Hum Reprod; 2005 Jun 15; 20(6):1590-5. PubMed ID: 15705622 [Abstract] [Full Text] [Related]
39. Polymorphisms of the peroxisome proliferator-activated receptor-gamma and its coactivator-1alpha genes in Chinese women with polycystic ovary syndrome. Wang Y, Wu X, Cao Y, Yi L, Fan H, Chen J. Fertil Steril; 2006 May 15; 85(5):1536-40. PubMed ID: 16600233 [Abstract] [Full Text] [Related]
40. Study of association of IRS-1 and IRS-2 genes polymorphisms with clinical and metabolic features in women with polycystic ovary syndrome. Is there an impact? Christopoulos P, Mastorakos G, Gazouli M, Deligeoroglou E, Katsikis I, Diamanti-Kandarakis E, Panidis D, Creatsas G. Gynecol Endocrinol; 2010 Sep 15; 26(9):698-703. PubMed ID: 20210696 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]